Arcellx (ACLX) Common Equity (2021 - 2025)
Arcellx's (ACLX) quarterly Common Equity came in at $402.4 million in Q4 2025, down 11.53% year-on-year from $454.8 million in Q4 2024, and down 8.72% quarter-over-quarter from $440.8 million in Q3 2025.
Arcellx (ACLX) Common Equity (2021 - 2025) Analysis & Trends
Arcellx's Common Equity history runs 5 years deep, the most recent figure standing at $402.4 million for Q4 2025.
- On a quarterly basis, Common Equity fell 11.53% year-over-year to $402.4 million in Q4 2025; TTM through Dec 2025 was $402.4 million, a 11.53% decrease from a year earlier, with the FY2025 full-year figure at $402.4 million, down 11.53% from the prior year.
- Common Equity retreated to $402.4 million in Q4 2025 per ACLX's latest filing, from $440.8 million in the prior quarter.
- Across five years, Common Equity topped out at $496.6 million in Q1 2024 and bottomed at -$205.0 million in Q4 2022.
- The 5-year median for Common Equity is $313.7 million (2022), against an average of $255.9 million.
- Biggest YoY gain for Common Equity was 464.65% in 2022; the steepest drop was 68.67% in 2022.
- Year by year, Common Equity stood at -$121.5 million in 2021, then tumbled by 68.67% to -$205.0 million in 2022, then soared by 336.82% to $485.4 million in 2023, then declined by 6.3% to $454.8 million in 2024, then dropped by 11.53% to $402.4 million in 2025.
- Per Business Quant, the three latest ACLX Common Equity figures stand at $402.4 million (Q4 2025), $440.8 million (Q3 2025), and $392.2 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 402.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 402.35 Mn |
| Sep 30, 2025 | 440.78 Mn |
| Jun 30, 2025 | 392.22 Mn |
| Mar 31, 2025 | 416.91 Mn |
| Dec 31, 2024 | 454.79 Mn |
| Sep 30, 2024 | 483.02 Mn |
| Jun 30, 2024 | 487.16 Mn |
| Mar 31, 2024 | 496.57 Mn |
| Dec 31, 2023 | 485.38 Mn |
| Sep 30, 2023 | 266.13 Mn |
| Jun 30, 2023 | 293.67 Mn |
| Mar 31, 2023 | 303.72 Mn |
| Dec 31, 2022 | -204.95 Mn |
| Sep 30, 2022 | 236.28 Mn |
| Jun 30, 2022 | 323.62 Mn |
| Mar 31, 2022 | 227.94 Mn |
| Dec 31, 2021 | -121.52 Mn |
| Sep 30, 2021 | -103.80 Mn |
| Jun 30, 2021 | -88.75 Mn |
| Mar 31, 2021 | -74.23 Mn |